WPI 3385 (Bupropion Extended-Release (SR) 200 mg)

Pill imprint WPI 3385 has been identified as Bupropion hydrochloride extended-release (SR) 200 mg.

Bupropion is used in the treatment of sexual dysfunction, ssri induced; major depressive disorder; depression; adhd; anxiety (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 3385

Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385
Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385  Front
Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385  Back
Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385
Bupropion hydrochloride extended-release (SR) 200 mg WPI 3385
Bupropion hydrochloride extended-release (SR)
Imprint:
WPI 3385
Strength:
200 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antidepressants
Smoking cessation agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3385
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0020 Rebel Distributors Corp (repackager)
43063-0183 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)